Cocrystal Pharma, Inc. (COCP) is an innovative biotechnology firm dedicated to the development of antiviral therapies targeting serious and chronic viral infections. With a strong research foundation and a focus on advancing its proprietary drug candidates, the company aims to address unmet medical needs in the antiviral space. Headquartered in Bothell, Washington, Cocrystal leverages advanced technologies to potentially transform treatment paradigms and improve patient outcomes worldwide.